Parcourir et rechercher des captures

Biodisponibilité et bioéquivalence ICH M9 Dispense de démonstration de bioéquivalence fondée sur le système de classification biopharmaceutique Ligne directrice: Conduite et analyse des études de biodisponibilité comparatives [2018-06-08] Normes en matière d'études de…

Examen de la réglementation des essais cliniques : mesures ciblées pour un cadre renforcé (Version PDF - 102 Ko) Contact: Examen du cadre de réglementation des essais cliniques Direction générale des produits de santé et des aliments Santé Canada Mars 2008 Table des matières 1…

Quarterly Financial Report for the Quarter Ended December 31, 2025 Table of contents Introduction Highlights of fiscal quarter and fiscal year-to-date results Risk and uncertainties Significant changes related to personnel, operations and programs Annex A - Statement of…

Annual Report on Fighting Against Forced Labour and Child Labour in Supply Chains For the Financial Reporting Period: April 1, 2024, to March 31, 2025 General Overview This annual report is prepared in accordance with the requirements of the Fighting Against Forced Labour and…

Reporting obligations under the Fighting Against Forced Labour and Child Labour in Supply Chains Act Report submitted by the Canadian Institutes of Health Research (CIHR) for Fiscal Year 23/24 On this page Part 1: Identifying Information Part 2: Report Contents 2.1 Structure,…

Annexe 7 aux lignes directrices sur les bonnes pratiques de fabrication - certaines drogues en vente libre (GUI-0066) : Aperçu Aperçu Orientation Définitions Références Télécharger le format de rechange (Format PDF, 735 ko, 26 pages) Organisation : Santé Canada Date publiée : 29…

Summary of Pharmaceutical Survey Findings on R&D Spending and Investments by Rx&D Members - 2010 Canada's Research-Based Pharmaceutical Companies (Rx&D) (the " Company" ) on behalf of the Steering Committee, made up of members from: Rx&D; Industry Canada; Patented Medicine Prices…

Canadian Institutes of Health Research – 2017 to 2018 Fees Report At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada’s health research investment agency, we collaborate with partners and researchers to support the…

2012-13 Annual Report on the Administration of the Privacy Act April 1, 2012 – March 31, 2013 Introduction The Canadian Institutes of Health Research (CIHR) is pleased to submit to Parliament its annual report on the administration of the Privacy Act for the fiscal year…

2011-12 Annual Report on the Administration of the Privacy Act April 1, 2011 – March 31, 2012 Introduction The Canadian Institutes of Health Research (CIHR) is pleased to submit to Parliament its annual report on the administration of the Privacy Act for the fiscal year…